4-(1h- imidazol- 5- yl) -1h-pyrrolo [2, 3-b] pyridines for use in the treatment of leukaemias, lymphomas and solid tumors

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Science. Official publication website can be found on muni.cz.

Authors	BRYJA Vítězslav JANOVSKÁ Pavlína GREGOROVÁ Michaela NĚMEC Václav KHIRSARIYA PrashantKumar PARUCH Kamil
Year of publication	2022
Type	Patent
MU Faculty or unit	Faculty of Science
Publisher	European Patent Office
State	Germany
Patent's number	EP3774795
web	https://worldwide.espacenet.com/patent/search/family/061837684/publication/EP3774795B1?q=pn%3DEP3774795B1
Description	The present invention relates to novel 4-(1H-imidazol-5-yl)-1H-pyrrolo[2,3-b]pyridine compounds which are useful in the treatment of lymphomas, leukaemias, and solid tumors.
Related projects:	Preclinical Progression of New Organic Compounds with Targeted Biological Activity CZ-OPENSCREEN: National Infrastructure for Chemical Biology